Biological evaluation of medical devices - Identification and quantification of degradation products from metals and alloys1 Scope This part of ISO 10993 provides guidance on general requirements for the design of tests for identifying and quantifying degradation products from finished metallic medical devices or corresponding material samples finished as ready for clinical use. It is applicable only to those degradation products generated by chemical alteration of the finished metallic device in an in vitro accelerated degradation test. Because of the accelerated nature

It includes general requirements for all reports and supplementary requirements for reports on cumulative experience with devices and estimates of future clinical performance for devices

This document defines documentation rules for standards that define interfaces between or among system elements of an ITSreference architecture

Get a competitive advantage with good supply chain continuity management (SCCM)

BS EN 50288-5-2:2013 supersedes BS EN 50288-5-2:2003

separate control and complex control

according to IEC TS 62351‑8:2011

02 ng/m3 to approximately 2 ng/m3 for DBahA

Why should you use BS EN 61988-3-2 - Electrical interface of PDP

This standard is not applicable to mineral feeds

protection against electrical shock

and secure transportation through large transportable vacuum insulated cryogenic vessels

No requirements are specified for shape or dimensions of containers for solid dosage forms and powders but the shape and proportions of containers for semi-solids are defined